Pharmaceuticals Search Engine [selected websites]

Blog Archive

Thursday, April 1, 2010

ResMed : Next-Generation CPAP Series in Europe

ResMedFeb 22, 2010- The S9 Series Offers More Comfort & Sleek Design; New CPAP Expected to Increase Patient Compliance - ResMed (NYSE:RMD), a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, introduced its new cutting-edge sleep apnoea therapy platform called the S9 Series in Europe. The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes. The S9 Series is expected to help more sleep apnoea patients adhere to the treatment, but also help sleep professionals make more informed decisions.

The most effective treatment for sleep apnoea is Continuous Positive Airway Pressure (CPAP) therapy. In this non-invasive treatment, air is pressurised by a small device and delivered to the airway of the patient through a mask that fits on/over the nose, or nose and mouth. The pressurised air keeps the upper airway open and helps the person to get a restful night without interruptions caused by apnoeas.

"With patients across the world in mind, we are thrilled to introduce a true revolution in positive airway pressure therapy," ... ResMed's Press Release -